ONCOLife Articles
IMforte Study: Tecentriq Plus Lurbinectedin Extends Survival in ES-SC Lung Cancer
ONCOLife | 4 June 2025
Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization
ONCOLife
27 May 2025
START and OneOncology Partnership Expands Clinical Trials from Academia to Community
Clinical Trials
27 May 2025
DNA-Based Immunotherapy IMNN-001 Shows Survival Gains in Advanced Ovarian Cancer
Clinical Trials
23 May 2025
How the Integration of START and CURC Is Advancing Cancer Research and Clinical Trials
ONCOLife
22 May 2025
START Doses First Patient in Trial of mRNA-4106, a Pan-Tumor Therapy for Solid Tumors
Clinical Trials
15 May 2025
FDA Approves Emrelis as the First Targeted ADC for High c-Met Expressing Lung Cancer
FDA & EMA
15 May 2025
V Foundation and Cancer Vaccine Coalition Partner to Accelerate Breast Cancer Vaccine
ONCOLife
14 May 2025
10-Year Results Confirm Pertuzumab Combo Extends Survival in HER2+ Breast Cancer
Clinical Trials
14 May 2025
EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer
Clinical Trials
13 May 2025
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
